News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
150 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39122)
2019 (51337)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42567)
2024 (37443)
2025 (33092)
2026 (8667)
Month
January (2854)
February (3083)
March (3049)
April (3166)
May (3576)
June (3256)
July (3084)
August (3051)
September (3627)
October (3996)
November (3760)
December (3171)
Day
3 (175)
4 (194)
5 (187)
6 (176)
7 (131)
10 (121)
11 (134)
12 (155)
13 (130)
14 (129)
17 (127)
18 (156)
19 (119)
20 (149)
21 (120)
24 (139)
25 (164)
26 (151)
27 (149)
28 (90)
30 (3)
31 (150)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
3
4
5
6
7
10
11
12
13
14
17
18
19
20
21
24
25
26
27
28
30
31
FDA
Sorin Group S.p.A.'s Perceval Sutureless Aortic Valve Receives CE Mark Approval For Extended Age Indication
March 31, 2014
·
4 min read
Business
RegeneRx Biopharmaceuticals, Inc. Receives $1.35 Million Pursuant To Product License And Stock Purchase Agreement
March 31, 2014
·
1 min read
Drug Development
Cellceutix Reports 20 Percent Enrollment Completed In Phase 2b Trial Of Brilacidin As Short-Course Therapy For ABSSSI
March 31, 2014
·
4 min read
Business
Nevro Corp Strengthens Leadership Team With The Appointment Of David Caraway, MD, PhD As Chief Medical Officer
March 31, 2014
·
3 min read
Business
Nephros Inc. Reports 2013 Fourth Quarter And Full Year Financial Results
March 31, 2014
·
9 min read
BioMidwest
Karmanos Cancer Institute’s 32nd Annual Dinner April 26
March 31, 2014
·
4 min read
Pharm Country
ADMA Biologics, Inc. To Present Company Overview At The 13th Annual Needham Healthcare Conference
March 31, 2014
·
1 min read
Business
Cord Blood America, Inc. Announces 2013 Financial Results
March 31, 2014
·
3 min read
Business
American Bio Medica Corporation Reports Fourth Quarter And Year End 2013 Results
March 31, 2014
·
1 min read
Business
Juno Therapeutics Appoints Biotech Investment Banking Leader Steve Harr As CFO And Head Of Corporate Development
March 31, 2014
·
2 min read
Previous
4 of 15
Next